Trial intelligence / Profile preview

Long-Term Study of TS-071 in Type 2 Diabetes Mellitus With Renal Dysfunction

jRCT2080221504

Sponsor
Taisho Pharmaceutical
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) comparing TS-071 with Placebo (2 arms).

02

Drugs

luseogliflozin
03

Conditions

type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)

Beyond the preview

Go deeper on jRCT2080221504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call